Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease

NCT04003844 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Kawasaki Disease

Interventions

DRUG: Immunoglobulin G
DRUG: Acetylsalicylic acid

Sponsor

Green Cross Corporation